First Precision Medicine Clinical Trial for a Rare Adult Blood Cancer

Chronic myelomonocytic leukaemia using an Australian-invented monoclonal antibody or Vitamin C in combination with azacytidine
People
Project Status: Recruiting
Project administered by: University of Adelaide

People